Control of albuminuria in overt diabetic nephropathy: durability counts

被引：7
|
作者：
Glassock, Richard J. [1 ,2 ]
机构：
[1] Univ Calif Los Angeles, Geffen Sch Med, Los Angeles, CA 90095 USA
[2] 8 Bethany, Laguna Niguel, CA 92677 USA
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2016年 / 31卷 / 09期
关键词：
KIDNEY-DISEASE; MICROALBUMINURIA; PREDICTOR; METAANALYSIS; THERAPY;
D O I：
10.1093/ndt/gfv462
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
aEuro broken vertical bar The crucial point deserving of emphasis is that the enhancement as well as the durability of a decline in albuminuria with ARB treatment is an important surrogate for favorable outcomesaEuro broken vertical bar.
引用
收藏
页码：1371 / 1373
页数：3
相关论文
共 50 条
  • [1] Effect of sulphated glycosaminoglycans on albuminuria in patients with overt diabetic (type 1) nephropathy
    Tamsma, JT
    vanderWoude, FJ
    Lemkes, HHPJ
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (01) : 182 - 185
  • [2] Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy
    Scheele, Wim
    Diamond, Susan
    Gale, Jeremy
    Clerin, Valerie
    Tamimi, Nihad
    Le, Vu
    Walley, Rosalind
    Grover-Paez, Fernando
    Perros-Huguet, Christelle
    Rolph, Timothy
    El Nahas, Meguid
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (11): : 3459 - 3468
  • [3] Neutrophil elastase and myeloperoxidase mRNA levels are elevated in diabetic patients with overt nephropathy and are associated with albuminuria
    Biswas, S. K.
    Rinta, R. M.
    Haider, F.
    Fariduddin, M.
    Arslan, M. I.
    DIABETOLOGIA, 2018, 61 : S497 - S498
  • [4] Avosentan for Overt Diabetic Nephropathy
    Mann, Johannes F. E.
    Green, Damian
    Jamerson, Kenneth
    Ruilope, Luis M.
    Kuranoff, Susan J.
    Littke, Thomas
    Viberti, Giancarlo
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (03): : 527 - 535
  • [5] ALBUMINURIA AND THE PROGRESSION OF DIABETIC NEPHROPATHY
    STEFFES, MW
    CLINICAL CHEMISTRY, 1989, 35 (06) : 1237 - 1237
  • [6] PROGRESSION OF OVERT DIABETIC NEPHROPATHY (DN) - ROLE METABOLIC CONTROL
    MULEC, H
    BLOHME, G
    GRANDE, B
    BJORCK, S
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 453 - 453
  • [7] Finerenone for Albuminuria in Patients With Diabetic Nephropathy
    Feng, Yanhuan
    Zeng, Xiaoxi
    Fu, Ping
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (03): : 305 - 306
  • [8] ALBUMINURIA AND DIABETIC NEPHROPATHY - AN EVOLVING STORY
    WATTS, NB
    CLINICAL CHEMISTRY, 1991, 37 (12) : 2027 - 2028
  • [9] Clinical impact of albuminuria in diabetic nephropathy
    Wada, Takashi
    Shimizu, Miho
    Toyama, Tadashi
    Hara, Akinori
    Kaneko, Shuichi
    Furuichi, Kengo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2012, 16 (01) : 96 - 101
  • [10] Clinical impact of albuminuria in diabetic nephropathy
    Takashi Wada
    Miho Shimizu
    Tadashi Toyama
    Akinori Hara
    Shuichi Kaneko
    Kengo Furuichi
    Clinical and Experimental Nephrology, 2012, 16 : 96 - 101
12345